Our Team
休斯顿卫理公会队
Dr. Polly Niravath, MD
Lois E, and Carl A. 戴维斯百年纪念协会
癌症研究教授，博士. 玛丽和罗恩·内拉癌症中心
学术研究所临床医学副教授
Houston Methodist
EDUCATION
威尔，康奈尔医学院
CLINICAL INTERESTS
Breast Biopsy
Breast Cancer
Chemotherapy
Pagets Disease
委员会认证
•医学肿瘤学|南加州大学，洛杉矶，加州| 2011
• Hematolofy | 2011
•内科| 2008
Residency
贝勒医学院-休斯顿，德克萨斯州| 2008
FELLOWSHIP
贝勒医学院-休斯顿，德克萨斯州| 2011
AFFLIATED医院
休斯顿卫理公会医院
CENTER MEMBERSHIP
休斯顿卫理公会医生. 玛丽和罗恩·尼尔癌症中心
德克萨斯南方大学队
Veronica B . Ajewole，药学博士，BCOP
药学实践助理教授
药学与健康科学学院
德克萨斯南方大学
克莱本街3100号，纳布里特科学大厦123室
Houston TX 77004
Tel: 713-313-1217
Email: veronica.ajewole@sophieboon.com
临床药学专家，肿瘤学
休斯顿卫理公会医院
肿瘤学兼职助理教授
休斯敦卫理公会学院
EDUCATION
Postgraduate year 2 Oncology Pharmacy Residency, 休斯顿卫理公会医院, Houston, TX
研究生一年级药房实习，休斯顿卫理公会医院，休斯顿，德克萨斯州
德克萨斯南方大学药学博士，休斯顿，德克萨斯州
B.尼日利亚生物化学学士学位
RESEARCH INTERESTS
•肿瘤和口服化疗
•社区参与
•健康差异
•母婴保健
RESEARCH GRANTS
• “Development of predictive model and social determinants-based interventions for aggressive prostate cancer among African American males”. 25万美元，机构:医疗保险中心 & 医疗补助服务，少数族裔健康办公室，少数族裔研究资助计划. 2020年10月至2022年9月. Role:
• “Center for Biomedical and Minority Health Research (CBMHR)” NIH/NIMHD-Research Centers in Minority Institutions Program (RCMI), U54MD007605, $8,632,113, 2020-2025, Role: Director, 社区参与核心
•“卡培他滨的药物治疗管理和重新处方”, NIH/NIMHD-RCMI, pilot project, U54MD007605, $32,000, 2019-2020, Role: PI, Pilot project $32,000
• “德克萨斯南方大学 乳腺癌筛查 and Prevention Center” Agency: Susan G. Komen Breast Cancer Foundation, $59,992, April 2019 – March 2020, Role: Program Co-Director
• “德克萨斯南方大学 乳腺癌筛查 and Prevention Center” Agency: Susan G. Komen Breast Cancer Foundation, $50,000, April 2018 – March 2019, Role: Program Co-Director
•“提高服药依从性的口服化疗药物治疗管理”, Self-Care Abilities, and Quality of Life for Cancer Patients” Agency: 德克萨斯南方大学 Seed Grant Program, 2017年12月- 2018年11月, 职位:首席研究员6美元,000
获选奖项及荣誉
2020年助理助理
2020 Best in clinical category poster presentation, National Pharmaceutical Association
2019年休斯顿卫理公会癌症研讨会临床类最佳海报展示
2019 Program Mentor, Maternal and Child Health Student Training for Academic Readiness and Success
2019年旅游奖，休斯顿卫理公会癌症中心
2018年度导师提名，德克萨斯南方大学
2017年学院种子基金奖
COURSES
肿瘤学实践经验(6学时)
Pharmacotherapy IIIA: Cardiovascular system disorders (3 credit hour), Team taught course
药物治疗IIIA:免疫系统疾病(4学时)，团队授课
药物治疗IIA:内分泌系统紊乱(3学时)团队授课
药物治疗IA:神经(4学时)团队授课课程
药学实践II(2学时)团队授课课程
Integrated Pharmacy Practice lab II (2 credit hour) Course coordinator, Team taught course
精选出版物，专利，书籍章节，邀请演讲
Publications
• Ajewole VB, Ngujede AE, Oduguwa E, Dongarwar D, Kaur M, Knight C, Jackson M, Nguyen U, Roshan T, Simpson J, Vouffo I, Olaleye OA, Salihu HM. A Surveillance System for the Maternal and Child Health (MCH) Population During the COVID-19 Pandemic. Int J MCH AIDS. 2020;9(3):350-353. doi: 10.21106/ijma.411. Epub 2020 Aug 9.
• Thompson J, Onyenaka C, Oduguwa E, Dongarwar D, Gendra S, Coker V, Kutse S, Blanco M, Nwangwu O, King C, Enamorado E, Bakare O, Ajewole VB, Spooner KK, Salemi JL, Aliyu MH, Salihu HM, Olaleye OA. Trends and Racial/Ethnic Disparities in the Rates of Pre-eclampsia by HIV Status in the US. J种族和民族健康差异. 2020 Aug 4;. doi: 10.1007/s40615-020-00826-3.
• Dongarwar D, Taylor J, Ajewole V, Anene N, Omoyele O, Ogba C, Oluwatoba A, Giger D, Thuy A, Argueta E, Naik E, Salemi JL, Spooner K, Olaleye O, Salihu HM. 孕妇阑尾炎的趋势, 心脏骤停的风险, 母婴死亡率. World J Surg. 2020 Jul 31;. doi: 10.1007/s00268-020-05717-6. [Epub ahead of print] PubMed PMID: 32737556.
• Dongarwar D, Ajewole VB, Oduguwa E, Ngujede A, Harris K, Ofili TU, Olaleye OA, Salihu HM. Role of Social Determinants of Health in Widening Maternal and Child Health Disparities in the Era of Covid-19 Pandemic. Int J MCH AIDS. 2020;9(3):316-319. doi: 10.21106/ijma.398. Epub 2020 Jul 29. PubMed
• Ajewole VB, Cox JE, Swan JT, Chikermane SG, Lamoth B, Iso T, Okolo LO, Ford CL, Schneider AM, Hobaugh EC, Baker KR. Incidence of chemotherapy-induced peripheral neuropathy within 12 weeks of starting neurotoxic chemotherapy for multiple myeloma or lymphoma: a prospective, single-center, observational study. Support Care Cancer. 2020年4月,28 (4):1901 - 1912. doi: 10.1007/s00520-019-05006-6. Epub 2019 Jul 29. PubMed PMID: 31359183
•Ajewole VB, Solomon JM, Schneider AM, Heyne KE. Development and implementation of an electrolyte replacement protocol in the outpatient oncology infusion centers of a large academic healthcare system. J Oncol Pharm Pract. 2020年3月4日;:1078155220907671. doi: 10.1177/1078155220907671. [Epub ahead of print] PubMed PMID: 32131681
•Solomon JM, Ajewole VB, Schneider AM, Sharma M, Bernicker EH. 评估处方模式, adverse effects, 以及门诊癌症中心口服化疗药物的相互作用. J Oncol Pharm Pract. 2019年10月,25 (7):1564 - 1569. doi: 10.1177/1078155218798150. Epub 2018 Aug 31. PubMed PMID: 30170514.
•Ajewole VB, Edmondson L, Mclean E, Heyne K, Rice L. New Formulation of Bendamustine and Occurrence of Phlebitis: A Report of Two Unique Patient Cases. 血液学与肿瘤学杂志. 2019; 9(2):32.
•秦强，陈国强，陈国强，陈国强. Successful treatment of a stage IIIC small-cell carcinoma of the ovary hypercalcemic subtype using multi-modality therapeutic approach. Ecancermedicalscience. 2018;12:832. doi: 10.3332/ecancer.2018.832. eCollection 2018. PubMed PMID: 29910829; PubMed Central PMCID: PMC5985749
Posters
•Ajewole VB, Oyinkansola Akindele, Uzoamaka Abajue, Okwuoma Ndulue, Jazzmin J. Marshall, Yhenew T. Mossi. Racial Disparity and Representation in Clinical Trials Leading to the Approval of Oral Chemotherapy from 2017-2019. 休斯顿卫理公会癌症研讨会，2020年8月
• Ajewole VB, Collins Enwerem, Oyinkansola Akindele, Solomon JM, Schneider AM, Heyne KE. 电解质替代方案介绍，TSHP会议，2020年9月
•Ajewole VB, Ka Wong, michel Nguyen, Andre Phillips, Zain Malik. Impact of a Pharmacist-led Oral Chemotherapy Medication Therapy Management (MTM) Program in a Large Academic Medical Center. TSHP会议，2020年9月
•Ajewole VB, Tasha Roshan, Alma Mendoza，谢欢，陈媛，Kirk Heyne. 药物治疗管理对口服化疗药物卡培他滨的影响. 休斯顿卫理公会癌症研讨会，2020年8月
•Ajewole VB, Adesola Adenote, aaron george Fung, Leslie Ibenana. Trends of oral chemotherapy approval by the Food and Drug Administration: A 10-year retrospective review. 休斯顿卫理公会癌症研讨会，2020年8月
•Ajewole VB, Oyinkansola Akindele, Uzoamaka Abajue, Okwuoma Ndulue, Jazzmin J. Marshall, Yhenew T. Mossi. Racial Disparity and Representation in Clinical Trials Leading to the Approval of Oral Chemotherapy from 2017-2019. 休斯顿卫理公会癌症研讨会，2020年8月
•Ajewole VB, Tasha Roshan, Alma Mendoza，谢欢，陈媛，Kirk Heyne. 药物治疗管理对口服化疗药物卡培他滨的影响. Dec 2019. RCMI全国研讨会.
• Ajewole VB, Collins Enwerem, Oyinkansola Akindele, Solomon JM, Schneider AM, Heyne KE. 电解质替代方案介绍，ASHP年中临床会议. Dec 2019
•Olaleye OA和Ajewole VB. 临床前药物开发和社区参与. University of Houston and Baylor College of Medicine Teaming Workshop, UH Student Center South. May 23, 2019.
•Ajewole VB, Tran Mary, Bianca Alexandra. Oral chemotherapy Medication Therapy Management, TSU research week poster presentation, March 2019.
• Onyinye Nwangwu, Jamalena Thompson, Sumaya Gendra, Vidella Coker, Seun Kutse, Mayra Blanco, Collins Onyenaka, Charlee King, Elza Enamorado, Oluwatoyin Bakare, Veronica B Ajewole, Kiara K Spooner, Jason L Salemi, Hamisu M Salihu, 和Omonike A Olaleye. The Prevalence of Pre-eclampsia in Hospital Pregnancy Discharges: Racial Disparities and Maternal HIV Status. MCH组1,TSU研究周，2019年3月.
• Ajewole VB, Collins Enwerem, Oyinkansola Akindele, Solomon JM, Schneider AM, Heyne KE. Electrolyte replacement protocol presentation, Houston Methodist Cancer symposium, August 2019.
• Ajewole VB, Collins Enwerem, Oyinkansola Akindele, Solomon JM, Schneider AM, Heyne KE. Implementation of electrolyte replacement protocol in a large academic institution: ASHP conference Dec 2019.
•Ajewole VB, Solomon JM, Schneider AM, Heyne KE. Implementation of electrolyte replacement protocol in a large academic institution: HOPA conference March 2018
•Ajewole VB, Tran Mary, Bianca Alexandra. Oral chemotherapy medication therapy management to improve medication adherence among cancer patients in an academic medical Center: Houston Methodist Cancer Symposium, August 2018
•Ajewole VB, Tran Mary, Bianca Alexandra. Oral chemotherapy medication therapy management to improve medication adherence among cancer patients in an academic medical Centre: Dec 2018. ASHP年中临床会议
• Ajewole VB, Cox JE, Swan JT, Chikermane SG, Lamoth B, Iso T, Okolo LO, Ford CL, Schneider AM, Hobaugh EC, Baker KR. Characterization of Chemotherapy- Induced Peripheral Neuropathy: A Prospective Pilot Study; 5th Annual Houston Methodist Cancer Symposium, August 2017
•Solomon JM, Ajewole VB, Schneider AM, Sharma M, Bernicker EH. 评估处方模式, adverse effects, and drug interactions of oral chemotherapy agents; ASHP Clinical conference December 2017 ASHP Clinical conference
•Solomon JM, Ajewole VB, Schneider AM, Sharma M, Bernicker EH. 评估处方模式, adverse effects, and drug interactions of oral chemotherapy agents; Vizient Clinical conference December 2017 Vizient Clinical conference
•Olaleye OA, Isichei AC, Ajewole V, Bhat S. and Liu JO. The Discovery and Development of New Chemotherapeutic Agents for Hospital Acquired Infections. 2017年9月，加州帕洛阿尔托，斯坦福大学，斯坦福医学X.
Invited Talks
• Ajewole VB. “Pre-Clinical Drug Characterization and Formulation Development” 2nd Annual ADME: Lead Characterization and Optimization Conference, Oct. 22 2020
• Ajewole VB. Electrolyte replacement protocol presentation, NCODA Annual conference, Orlando, Florida. October 2019
• Ajewole VB. (目标+努力)导师=巨大的影响力, RCMI年会, 德州南方大学研究周2019年3月
• Ajewole VB. 肿瘤药物相互作用的临床明珠. 2017年秋季德州南方大学药学讲师会议. 药学教育认可委员会继续教育.
专业服务和会员资格
• Breast Cancer Awareness Education sessions at Faith-Based and Community-Based Organizations
• Colon Cancer Awareness Education sessions at Faith-Based and Community-Based Organizations
• Prostate Cancer Awareness Education sessions at Faith-Based and Community-Based Organizations
•同行评议:《比较靠谱的赌博大平台》, 药学技术与患者教育与咨询杂志
• Clinical rotation Preceptor, PGY2 Oncology residency program, 休斯顿卫理公会医院
•辅修和主修项目导师, PGY2肿瘤学住院医师项目和PGY1药学住院医师项目, 休斯顿卫理公会医院
•继续教育讲师, PGY2肿瘤学住院医师项目和PGY1药学住院医师项目, 休斯顿卫理公会医院
乳腺癌筛查项目经理 & Prevention Center
德克萨斯南方大学药学院 & 健康科学|纳布里特科学大厦3100 cleburn. 139B室|休斯顿TX 77004
(713)-313-4424| xiomara.ardon@sophieboon.com
Education | 德克萨斯理工大学健康科学中心，公共卫生硕士